This is the website for the collection and evaluation of abstracts for two distinct events. The first is the 2nd SOHO Italian Conference to be held in Rome on 22, 23 and 24 September 2020 while for the second event scroll down to the School of Medicine section. Regardless of what your interest will be, by clicking on the above menu you can access the main sections [Create account], [Log-In/Authors] and [Log-In/Reviewers] and, depending on the permissions you have and the progress of the work, you will be able to access the functions of the site.
it will be possible to submit, print and/or correct abstracts until the deadline of AUGUST 31, 2020, connecting ONLY to this site and using the online procedure. Subsequently, the Organizing Secretariat will close the submission and the abstracts inserted won't be anymore modifiable as well as it won't be possible to submit new ones.
All abstracts in the database will be made accessible to the Auditors for the evaluation and selection of those intended both for presentation as oral communication and those intended for presentation as posters.
All abstracts will be published in the supplement of the journal Hematology Reports; abstracts not selected for oral or poster presentation will be published with the term "published only", unless specifically requested otherwise through a selection in the abstract registration form. Notification of acceptance (or non-acceptance) will be communicated to the Correspondent Author by September 30, 2020, to the e-mail address indicated when creating the corresponding author's account. For any problem related to the entry, please use the address email@example.com specifying the problem encountered.
The only form allowed to send abstracts is through the online procedure. We will not accept abstracts submitted in other forms (fax, regular mail, etc.). All abstracts must be written in English.
WARNINGS AND SPECIAL NOTES
We will not accept abstracts related to works already published. For each abstract accepted as a communication or poster, the First Author or who will present the work for him, must be regularly registered at the Congress.
INSTRUCTIONS FOR FILLING IN THE FORMS
Insert in the form all the required data of the corresponding author to whom all correspondence will be addressed.
TOPICS: From the drop down menu select one of following:
• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Multiple Myeloma
• Non Hodgkin and Hodgkin Lymphomas
• Chronic Lymphocytic Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms
• Rare Diseases
• Health management
• Supportive Care and Quality of Life
TITLE: in CAPITAL and English;
QUALIFICATION: e.g. Medical Director, Associate Professor…;
Date of birth: Of the first author;
AUTHORS: First author (First Name and Surname in full) and follow all the others in the order of contribution (e.g. M. Rossi, G. Bianchi, A. Verdi.). Always separated by a comma;
CONFLICT OF INTEREST: please specify any conflicts of interest of the first author. Please follow the following instructions: indicate "No conflict" if not present, or the list of subjects with commercial interests in the health sector with which the first author has had relationships in the last two years, including financing relationships. Please note that to be in a situation of conflict of interest means the ownership of shares in companies operating in the health sector, the employment relationship with them, the royalties received by the same companies, while it is not intended to have carried out studies, research or consultancy.
AFFILIATIONS: report the institutions to which each author belongs, separated by a comma or a return to head.
CITIES: report the cities of the institutions to which each author belongs, separated by a comma.
ABSTRACT TEXT: The abstract text (in English) must be divided into four sections:
Insert "text only" without any formatting. 3˙000, including spaces, is the maximum number of characters allowed for the body of the text only excluding Title, Names and Affiliations. The use of commonly used abbreviations such as MDS, ALL, PCR, etc. will be allowed, provided that the use does not give rise to interpretative doubts. All the characters of the Italian keyboard are allowed and can be typed, including accented letters, Greek letters and mathematical symbols with the exclusion of apices and subscripts not consensual.
It's recommended to save the manuscript in plain text format, then open and copy from it the texts to be pasted in the form fields.
The Second SOHO Italian Conference, in bringing together leading SOHO experts and top Italian researchers in acute leukemias, MPDs and MDSs, aims to consolidate the Italian Hematology-SOHO partnership.
It also serves to spread the importance to the Italian Scientific Community about the new scientific society “ITALIAN SOCIETY OF HEMATOLOGIC ONCOLOGY” (SOHO ITALY).
The aim of the association is the integration of the clinical-scientific activities of IRST Meldola and MD ANDERSON CANCER CENTER and the improvement of the clinical-therapeutic approach to patients with hematologic malignancies.
The Society “SOHO ITALY” is represented by G. Martinelli and C. Cerchione (IRST MELDOLA) and H. Kantarjian, E. Jabbour, M. Konopleva, N. Daver, MD ANDERSON CANCER CENTER)
The Cancer Institute of Romagna (IRST) breaks new ground in multiple cancer research fields, with outstanding clinical programs, innovative preclinical research, and educational excellence.
IRST provides state of the art diagnosis and treatment a wide range of cancer fields, in line with an excellent healthcare system. The Institute offers precision medicine treatments through a multidisciplinary approach, which guarantees the most effective interventions for each patient.
The Institute is a multi-specialty center with some high complexity clinical specialties such as radiometabolic therapy, last-generation radiotherapy treatments, cellular therapies, immunotherapy, and dedicated hospital ward and outpatient day hospital.
The Society of Hematologic Oncology (SOHO) was established as a non-profit organization in 2012 to promote worldwide research (education, prevention, clinical studies and patient care) into hematologic malignancies and related disorders. The SOHO network represents a point of reference for physicians and other healthcare professionals from more than 100 countries whose common aim is to find innovative and effective treatments for the myriad of diseases of hematological origin.